Paper407250
Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay.
Pollack M and 1 other. J Clin Microbiol, 1977. Cited by 28 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay. Papers, record 407250. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/407250
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Bacterial | Major topic |
| Antitoxins | Major topic |
| Hemagglutination Tests | Major topic |
| Pseudomonas Infections | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Animals | |
| Chromium | |
| Erythrocytes | |
| Humans | |
| Sheep |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 404,244 | Exotoxin production by clinical isolates of pseudomonas aeruginosa. | Infect Immun | 1977 | https://conductscience.org/library/papers/404244 | PubMed |
| 2 | 825,470 | Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection. | Infect Immun | 1976 | https://conductscience.org/library/papers/825470 | PubMed |
| 3 | 820,647 | Pseudomonas aeruginosa exotoxin: purification by preparative polyacrylamide gel electrophoresis and the development of a highly specific antitoxin serum. | Infect Immun | 1976 | https://conductscience.org/library/papers/820647 | PubMed |
| 4 | 4,169,033 | Chromic chloride: a coupling reagent for passive hemagglutination reactions. | J Immunol | 1967 | https://conductscience.org/library/papers/4169033 | PubMed |
| 5 | 4,202,883 | Purification and characterization of Pseudomonas aeruginosa exotoxin. | Infect Immun | 1974 | https://conductscience.org/library/papers/4202883 | PubMed |
| 6 | 4,170,633 | A new rapid method for genetic typing of human immunoglobulins. | J Immunol | 1968 | https://conductscience.org/library/papers/4170633 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,821,202 | Antibody response to Pseudomonas aeruginosa exoproducts in cancer patients. | J Clin Microbiol | 1982 | https://conductscience.org/library/papers/6821202 | PubMed |
| 6,788,700 | Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids. | Infect Immun | 1981 | https://conductscience.org/library/papers/6788700 | PubMed |
| 6,404,823 | Protective immunization against chronic Pseudomonas aeruginosa pulmonary infection in rats. | Infect Immun | 1983 | https://conductscience.org/library/papers/6404823 | PubMed |
| 6,358,257 | Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6358257 | PubMed |
| 3,924,607 | Evaluation of three serological tests for detection of antibody to Pseudomonas aeruginosa in human sera. | Eur J Clin Microbiol | 1985 | https://conductscience.org/library/papers/3924607 | PubMed |
| 2,861,092 | Trafficking of Pseudomonas exotoxin A in mammalian cells. | Eur J Clin Microbiol | 1985 | https://conductscience.org/library/papers/2861092 | PubMed |
| 429,553 | Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man. | J Clin Invest | 1979 | https://conductscience.org/library/papers/429553 | PubMed |
| 417,031 | Role of exotoxin and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa. | Infect Immun | 1978 | https://conductscience.org/library/papers/417031 | PubMed |
| 417,028 | Toxicity of Pseudomonas aeruginosa exotoxin A for human macrophages. | Infect Immun | 1978 | https://conductscience.org/library/papers/417028 | PubMed |
| 415,008 | Purification of Pseudomonas aeruginosa exotoxin by affinity chromatography. | Infect Immun | 1978 | https://conductscience.org/library/papers/415008 | PubMed |
| 415,004 | Mechanism of action of Pseudomonas aeruginosa exotoxin A in experimental mouse infections: adenosine diphosphate ribosylation of elongation factor 2. | Infect Immun | 1978 | https://conductscience.org/library/papers/415004 | PubMed |
| 412,786 | Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections. | Infect Immun | 1977 | https://conductscience.org/library/papers/412786 | PubMed |
| 115,899 | Enzyme-linked immunosorbent assay for Pseudomonas aeruginosa exotoxin A. | J Clin Microbiol | 1979 | https://conductscience.org/library/papers/115899 | PubMed |
| 110,687 | Production of exotoxin A by Pseudomonas aeruginosa in a chemically defined medium. | Infect Immun | 1979 | https://conductscience.org/library/papers/110687 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/407250
GET https://conductscience.org/api/papers/v1/407250/authors